Calling for advocacy, education and public policy actions on pain control for patients with cancer in Africa by Krause, Rene et al.
  1Krause R, et al. ESMO Open 2020;5:e000757. doi:10.1136/esmoopen-2020-000757
Open access 
Calling for advocacy, education and 
public policy actions on pain control for 
patients with cancer in Africa
Rene Krause  ,1 Anna Nyakabau,2 Liz Gwyther Gwyther,1 Emmanuel Luyirika,3 
Stein Kaasa4 
Correspondence
To cite: Krause R, Nyakabau A, 
Gwyther LG, et al. Calling 
for advocacy, education and 
public policy actions on pain 
control for patients with 
cancer in Africa. ESMO Open 
2020;5:e000757. doi:10.1136/
esmoopen-2020-000757
Received 21 March 2020
Revised 4 April 2020
Accepted 6 April 2020
1Family Medicine, University 
of Cape Town, Rondebosch, 
Western Cape, South Africa
2Oncology, Parirenyatwa Group 
of Hospitals, Harare, Zimbabwe
3head office, African Palliative 
Care Association, Kampala, 
Kampala, Uganda
4Department of Oncology, Oslo 
University Hospital, Oslo, Norway
Correspondence to
Dr Rene Krause;  
 rene. krause@ uct. ac. za
 ► http:// dx. doi. org/ 10. 1136/ 
esmoopen- 2020- 000833
© Author (s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. Published 
by BMJ on behalf of the 
European Society for Medical 
Oncology.
It is of serious concern that there is a lack of 
focus on pain management in patients with 
cancer in Africa. Most patients with cancer 
present with advanced disease on diagnosis, 
experiencing moderate to severe pain and in 
need of palliative care. Integration of palli-
ative and oncology care is recommended 
by European Society of Medical Oncology 
(ESMO) and by the World Health Assembly 
resolution WHA67.19.
At the recent ESMO Summit Africa 2020, 
a Pain Workshop was attended by represen-
tatives from across Africa. A consensus was 
reached to escalate concerns about lack of 
pain management in patients with cancer 
in Africa and to call on ESMO to make 
universal cancer pain control, and int egrated 
oncology and palliative care as an immediate 
priority area. Many developed countries are 
concerned about the overuse of opioids. 
However, in Africa, opioid consumption has 
decreased during the last decade from a low 
level below the global average to a totally inad-
equate level.1 This problem is confounded by 
an increase in the incidence of cancer, the 
advanced stage presentation of patients with 
cancer, few radiotherapy machines for cancer 
treatment and the quadruple burden of 
disease in Africa.2 The group agreed that pain 
management and palliative care are closely 
related and that the integration of universal 
access to pain control requires universal 
access to palliative care.
The ESMO pain guidelines and the African 
Palliative Care Association’s recommenda-
tion state that oral morphine remains the 
opioid of choice for patients with cancer 
with moderate to severe pain.3 4 Addressing 
barriers to implementing these guidelines 
require a strong advocacy and strong partner-
ships. Identified barriers are the inability of 
healthcare workers to assess, prescribe and 
communicate pain management details to 
patients and families. There are still many 
oncologists across Africa who have received 
little or no training in palliative care although 
this training for oncologists is advised by the 
WHA67.19 resolution on palliative care.5 
Misconceptions regarding palliative care 
and morphine use are still very common in 
African society. This may be driven by western 
propaganda around opioid phobia where 
there is a focus on stricter control measures 
due to opioid abuse.6
Afrocentric education on pain and pallia-
tive care and communication skills among 
healthcare providers can overcome these 
misconceptions. There are also misconcep-
tions among policymakers which feed into 
regulatory obstacles in the procurement 
and distribution of opioids; thus, resulting 
in minimal prescribing of opioids. These 
regulations include limitations on who can 
prescribe, where the morphine is available, 
and the time interval that it can be adminis-
tered. We are aware that opioids are mainly 
being prescribed in cancer centres only, 
by oncologists, for short periods of time, 
making access to opioids at primary care 
and in remote areas impossible. In order to 
get opioids at the right level of care, being 
dispensed in a safe and effective manner 
requires integrated and aligned policies, 
laws, education and advocacy. Uganda over-
came these obstacles by importing morphine 
powder for local reconstitution and enabling 
nurse prescribing. Universal access to opioids 
is recommended strongly by the WHO, the 
United Nations, the European Association of 
Palliative Care and the International Associ-
ation of Hospice and Palliative Care among 
others and this workshop calls for action to be 
taken to realise improved access.5 7 8
Training of healthcare workers in pain 
management and palliative care should be 
mandatory for all healthcare professionals in 
Africa, caring for patients with cancer across 
the continuum of care. In order to reach 
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these goals, palliative care education needs to be moni-
tored and evaluated at a national level and become a 
health indicator.
Morphine is an effective, inexpensive medication 
recognised as the gold standard for control of severe 
pain.3 The cost of a morphine should be regulated; thus, 
not leaving patients nor their families impoverished to 
obtain pain control nor palliative care.
A pan- African public health initiative is needed. ESMO 
has committed to assist in achieving better care for 
patients with cancer in Africa through the ESMO Desig-
nated Centre of Integrated Oncology and Palliative.9 We 
also ask for high- level advocacy to enforce regulations 
that monitor and evaluate morphine availability and palli-
ative care training. These are simple, achievable, low cost 
and high benefit interventions which will benefit patients 
with cancer and their families.
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